(Date:11/30/2009)...GO, Nov. 30 Dr. Jessica Torrente, ...ton University Medical Center in Washington, D.C.,...ecific Gamma Imaging (BSGI) in clinical practice a... breast cancer today at the annual meeting of the ..., "The purpose of the exhibit was to demonstrate h...
(Date:11/30/2009)...KVILLE, Md., Nov. 30 Nov... completed enrollment in the Phase II clinical stu...recommended strains) VLP vaccine candidate in heal.... This randomized, double-blind, active-controlle...immunogenicity of two different doses (15 mcg and ...
(Date:11/30/2009)... PDS, a leader in providing smart and eff...unces Pajama Pathology®, evolutionizing work-f...uo;gold standard’ software used by 8 of the ...on a ‘cost per slide’ basis. , ...mber 30, 2009 -- PDS has announced another evoluti...
(Date:11/30/2009)...STON and COPENHAGEN, Nov. 30 Exiqo...ay that the Harvard Medical School ICCB-Longwood S...a MicroRNA Screening Center of Excellence. ICCB-L... and associated hospitals and institutions, for hi... libraries. ,, MicroRNAs are a novel class of s...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3